Efficacy of the nanoparticle–drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I–IIa clinical trial
Titel:
Efficacy of the nanoparticle–drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I–IIa clinical trial
Auteur:
Keefe, S.M. Hoffman-Censits, J. Cohen, R.B. Mamtani, R. Heitjan, D. Eliasof, S. Nixon, A. Turnbull, B. Garmey, E.G. Gunnarsson, O. Waliki, M. Ciconte, J. Jayaraman, L. Senderowicz, A. Tellez, A.B. Hennessy, M. Piscitelli, A. Vaughn, D. Smith, A. Haas, N.B.